m⁶a Modification-Mediated LINC01547 Promotes Pancreatic Cancer Growth and Gemcitabine Resistance through Mir-34a-5p/MYH9 Axis

Researchers investigated the function of LINC01547 in PDAC progression and chemoresistance. LINC01547 was significantly upregulated in PDAC tissues and cell lines, and its high expression correlated with unfavorable patient outcomes.